Atlas Trials

Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children

Clinical trial NCT02747927 · COMPLETED

Trial details

NCT number
NCT02747927
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2016-04-26
Primary completion
2018-07-11
Enrollment
20099

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.